(Q51270406)

English

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

scientific article published on 27 March 2017

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Reza Malekzadeh

7

object named as

Reza Malekzadeh

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Maryam Sharafkhah

6

object named as

Maryam Sharafkhah

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Babak Nourinayyer

4

object named as

Babak Nourinayyer

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

5

object named as

Shahin Merat

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Hossein Poustchi

2

object named as

Hossein Poustchi

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

1

object named as

Fatemeh Mofidi

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

author name string

Zahra Yari

3

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Azita Hekmatdoost

8

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

publication date

27 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

British Journal of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

117

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

5

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

662-668

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Gut microbiome and nonalcoholic fatty liver diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

In vitro effects of selected synbiotics on the human faecal microbiota composition

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Dietary fibres as "prebiotics": implications for colorectal cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Intestinal microflora in early infancy: composition and development

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Diversity of the human intestinal microbial flora

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Characteristics and diagnosis of NAFLD/NASH.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Propionate as a health-promoting microbial metabolite in the human gut.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

21 January 2018

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

7 January 2021

based on heuristic

inferred from DOI database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

7 January 2021

based on heuristic

inferred from DOI database lookup

Review article: the role of butyrate on colonic function.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114517000204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0007114517000204

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/28345499

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51270406&oldid=2123430677"